Congenital cervical neck masses represent rare and potentially life-threatening fetal anomalies that pose acute risks of complete or partial airway obstruction at the moment of birth. In a clinical report published in Maternal Health, Neonatology and Perinatology, researchers and clinicians examined the multidisciplinary management and clinical courses of two neonates with distinct cervical masses who were delivered using ex-utero intrapartum treatment, known as an EXIT procedure. This specialized operative intervention allows maternal-fetal surgeons and pediatric specialists to secure a newborn’s compromised airway while maintaining functional uteroplacental blood circulation, thereby preventing acute asphyxiation before the infant fully transitions to independent pulmonary respiration.
During an EXIT to airway procedure, general anesthesia is administered to the mother to ensure profound uterine relaxation and preserve uteroplacental perfusion, allowing maternal blood flow to provide continuous oxygenation to the fetus. The surgical team initiates delivery through a Pfannenstiel incision and maternal hysterotomy, selectively exteriorizing only the fetal head and upper extremities while the remainder of the body remains inside the relaxed uterine cavity. This deliberate surgical staging preserves the fetal circulatory pattern, keeping the lungs fluid-filled and maintaining high pulmonary vascular resistance with right-to-left shunting across the ductus arteriosus and foramen ovale.
The first reported clinical case involved a 19-year-old pregnant woman presenting at 30 weeks and 3 days of gestation whose diagnostic evaluation at 35 weeks identified a large fetal cervical neck mass measuring 4.35 centimeters by 5.93 centimeters by 4.7 centimeters accompanied by severe polyhydramnios with an amniotic fluid index of 27 centimeters. Subsequent fetal magnetic resonance imaging conducted at 37 weeks failed to clearly delineate the fetal trachea, raising severe concerns regarding critical laryngopharyngeal compression.
At the time of delivery for the first case, the maternal amniotic fluid index had risen to 40 centimeters, necessitating an ultrasound-guided therapeutic amnioreduction of two liters of amniotic fluid prior to hysterotomy. Following exteriorization of the fetal head and right arm, pediatric otorhinolaryngologists attempted airway intubation but found that a standard 3.5-millimeter endotracheal tube could not be passed. The surgical team immediately transitioned to video laryngoscopy utilizing a 2.9-millimeter telescope paired with a 3.0-millimeter endotracheal tube, visualizing complete tracheal collapse distal to the vocal cords. The 3.0-millimeter tube was successfully guided past the obstruction, and placement was confirmed using a 2.2-millimeter flexible bronchoscope, securing the airway 25 minutes after partial delivery with stable fetal vitals throughout. Maternal blood loss was estimated at 1000 cubic centimeters with no blood transfusion required.
Postnatal diagnostic imaging of the first infant revealed a mixed cystic and solid cervical mass extending into the superior mediastinum and displacing bilateral carotid arteries and the trachea. Definitive surgical resection of the mass and partial thyroidectomy occurred on day of life 16. Postoperatively, the neonate experienced three failed extubation attempts between days of life 23 and 28 due to neck fluid reaccumulation, a Klebsiella respiratory infection, and progressive hypercarbia, prompting formal tracheostomy placement on day of life 29. Subsequent evaluations revealed severe 80 percent tracheal stenosis, tracheomalacia, vocal cord hypomobility, and secondary hypothyroidism requiring daily levothyroxine therapy, with the infant transitioning to inpatient rehabilitation at 9 months of age breathing via tracheostomy and feeding through a gastrostomy tube.
The second evaluated case centered on a 34-year-old multigravida woman whose routine 20-week anatomical survey appeared normal but who was found at 34 weeks and 3 days of gestation to carry a fetus with a bilateral cystic neck mass extending into the anterior thoracic cavity, alongside polyhydramnios with an amniotic fluid index of 27.12 centimeters. The right component measured 3.98 centimeters by 3.28 centimeters and the left measured 2.55 centimeters by 1.41 centimeters. Diagnostic fetal magnetic resonance imaging demonstrated mild compression and displacement of the upper aerodigestive tract with an estimated tracheoesophageal displacement index of 14 millimeters, although the airway remained patent to the carina.
Delivery in the second case proceeded without the need for pre-procedure amnioreduction as the amniotic fluid index measured 15.6 centimeters. Following maternal Pfannenstiel incision, amnioinfusion, and hysterotomy, the neonatal head and right arm were delivered, and the infant was successfully intubated with a 3.0-millimeter endotracheal tube within two minutes of life under continuous ultrasound fetal heart rate monitoring. Maternal quantitative blood loss was recorded at 1320 cubic centimeters without infectious complications or transfusion requirements. After cord division and transfer to the neonatal intensive care unit, postnatal imaging confirmed a trans-spatial, multiloculated cystic venolymphatic malformation extending across multiple deep neck compartments and the anterior mediastinum, supported by needle aspiration cytology yielding red blood cells and lymphocytes.
The clinical course of the second infant was complicated by upper airway compromise following an initial extubation on day of life 1, manifesting as persistent inspiratory stridor and tachypnea secondary to extensive supraglottic edema. After respiratory support with continuous positive airway pressure proved insufficient, the patient was reintubated on day of life 16 to facilitate local sclerotherapy using one unit of bleomycin, followed on day of life 19 by systemic targeted pharmacotherapy with oral sirolimus. Sirolimus was initiated at 0.8 milligrams per square meter every 12 hours with therapeutic drug monitoring targeting a serum trough concentration of 10 to 15 nanograms per milliliter. Following targeted medical therapy, the infant was successfully extubated on day of life 79 and ultimately discharged on day of life 141; at 9 months of age, she remains home without respiratory compromise, receiving continuing sirolimus therapy and oral-nasogastric feeding therapy.
The authors contextualized these distinct clinical trajectories within broader medical evidence regarding congenital cervical masses and EXIT indications. Congenital cervical teratomas, while rare, represent the primary indication for EXIT to airway interventions, accounting for an estimated 15 to 46 percent of all procedure candidates due to their solid composition, which can induce respiratory distress in up to 58 percent of neonates at birth and risks acute airway compromise from spontaneous hemorrhage. By contrast, lymphatic malformations represent the most common congenital neck anomaly overall; because they are predominantly cystic and fluid-filled, they are less frequently compressive, although approximately 11 percent of affected neonates still exhibit significant tracheal deviation, compression, or luminal obstruction.
The report highlighted that multidisciplinary standardized assessment protocols are essential when evaluating EXIT candidacy across North American centers, incorporating metrics such as magnetic resonance imaging displacement parameters, solid tissue composition, aerodigestive compression, and a tracheoesophageal displacement index exceeding 12 millimeters. Although EXIT procedures provide a controlled physiological window lasting up to 90 minutes to secure complex airways, the maternal requirement for profound uterine relaxation introduces maternal risks, including uterine atony and hemorrhage, with literature reporting maternal blood transfusion rates of approximately 6 percent. The authors concluded that individualized prenatal risk stratification, high-resolution diagnostic imaging, and coordinated multidisciplinary collaboration among maternal-fetal medicine, neonatology, pediatric surgery, and anesthesiology remain indispensable to optimizing outcomes in critical neonatal airway emergencies.
Subject of Research: Multidisciplinary management and clinical outcomes of neonatal ex-utero intrapartum treatment procedures
Article Title: Neonatal EXIT procedures: multidisciplinary management and outcomes
Article References: Liebmann, A., Tushman, L., Ismaiel, A., Hopp, S., & Nemerofsky, S. L. (2026). Neonatal EXIT procedures: multidisciplinary management and outcomes. Maternal Health, Neonatology and Perinatology, 12(1), Article 66. https://doi.org/10.1186/s40748-026-00314-2
Image Credits: AI Generated
DOI: 10.1186/s40748-026-00314-2
Keywords: EXIT procedure, congenital cervical mass, neonatal airway, cervical teratoma, venolymphatic malformation, maternal-fetal medicine, neonatology, pediatric otorhinolaryngology, fetal magnetic resonance imaging, amnioinfusion, tracheal compression, tracheostomy, sclerotherapy, sirolimus, polyhydramnios, endotracheal intubation, fetal circulation
News Source: Harold Sullivan. (November 19, 2026). EXIT Procedures Secure Complex Neonatal Airways During High-Risk Deliveries. Scienmag.



